Stay updated on RC48-ADC in HER2+ Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page’s displayed interface revision/version text has been updated from v3.5.2 to v3.5.3, with no indication of changes to the underlying clinical-trial information.
    Difference
    0.1%
    Check dated 2026-04-24T17:13:45.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:12:24.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page. This appears to be a minor metadata change rather than a substantive modification to study content.
    Difference
    0.1%
    Check dated 2026-03-20T00:43:48.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 to reflect the latest page version.
    Difference
    0.1%
    Check dated 2026-03-12T19:49:57.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision labels updated from v3.4.1 to v3.4.2, indicating a minor backend/content refresh. No study information or user-facing data are affected.
    Difference
    0.1%
    Check dated 2026-02-12T01:53:35.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision update from v3.4.0 to v3.4.1 was applied, with UI and layout tweaks across the page.
    Difference
    0.1%
    Check dated 2026-02-04T22:58:02.000Z thumbnail image

Stay in the know with updates to RC48-ADC in HER2+ Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page.